Back to BMRN Stock Lookup
Pages: 1 2 3 »» Last Page

BMRN – Analyst Ratings

Apr 7, 2014 09:42 AM BioMarin (BMRN) Target Bumped at Summer Street on Vimizim Launch
Mar 24, 2014 05:58 PM Goldman Sachs Cuts BioMarin Pharmaceutical Inc. (BMRN) to Neutral on Lack of Catalysts
Feb 19, 2014 08:40 AM BioMarin (BMRN) Target Goes to $85 at Nomura on VIMIZIM Approval
Jan 10, 2014 07:25 AM Barclays Downgrades BioMarin Pharmaceutical Inc. (BMRN) to Equalweight
Jan 8, 2014 07:56 AM Nomura Securities Starts BioMarin Pharmaceutical Inc. (BMRN) at Neutral, $75 PT
Nov 26, 2013 04:29 PM Piper Jaffray Resumed BioMarin Pharmaceutical Inc. (BMRN) at Overweight
Nov 19, 2013 02:14 PM BioMarin (BMRN): So Far Positive Vote Remains Likely - Wells Fargo
Sep 27, 2013 03:44 PM CHMP Moving BioMarin's (BMRN) Vimizim to 'Normal Review' Shouldn't be Material - Analyst
Sep 19, 2013 09:27 AM BioMarin Pharma (BMRN) Not Perfect Fit for Roche (RHHBY) - Wells Fargo
Sep 18, 2013 07:43 AM Stifel Nicolaus Downgrades BioMarin Pharmaceutical Inc. (BMRN) to Hold
Sep 5, 2013 01:14 PM Bernstein Names Potential Biotech M&A Targets (PTLA) (VRTX) (ALXN)
Jul 26, 2013 01:47 PM Goldman Sachs Remains Bullish on BioMarin (BMRN)
Jun 3, 2013 03:52 PM Deutsche Bank Upgrades BioMarin Pharma (BMRN) to Buy
Jun 3, 2013 01:09 PM BioMarin (BMRN) Decline Relates to High Expectations; Deutsche Bank Maintains Hold
Jun 3, 2013 12:25 PM Deutsche Boosts PT on Tesaro (TSRO) to $80; Likes Netupitant, Potential for Niraparib
Jun 3, 2013 10:51 AM Leerink Swann Says BioMarin (BMRN) BMN-673 Shows Promising Responses
Mar 20, 2013 01:30 PM BioMarin's BMN-701 has 60% Probability of Success, Says Analyst
Jan 22, 2013 08:20 AM Stifel Nicolaus Upgrades BioMarin Pharmaceutical Inc. (BMRN) to Buy
Jan 2, 2013 05:45 PM Janney Montgomery Scott Starts BioMarin Pharmaceutical Inc. (BMRN) at Buy
Nov 6, 2012 07:30 AM Brean Capital Downgrades BioMarin Pharmaceutical Inc. (BMRN) to Hold
Nov 5, 2012 03:02 PM Leerink Swann Sees Another 30% Upside in BioMarin (BMRN)
Nov 5, 2012 02:12 PM Baird Expects Q413 Launch of BioMarin's (BMRN) GALNS
Oct 3, 2012 07:46 AM Jefferies Says GALNS to drive 30% Upside in BioMarin (BMRN)
Sep 5, 2012 08:56 AM Canaccord Genuity Maintains a 'Buy' on BioMarin Pharmaceutical (BMRN); Framing the GALNS Case
Aug 27, 2012 07:17 AM Deutsche Bank Downgrades BioMarin Pharmaceutical Inc. (BMRN) to Hold; Risk/Reward Into Phase 3 GALNS
Aug 24, 2012 12:23 PM UPDATE: Barclays Starts BioMarin Pharmaceutical Inc. (BMRN) at Overweight; Three Shots on Goal
Aug 22, 2012 09:34 AM Baird Reiterates an 'Outperform' on BioMarin Pharmaceutical (BMRN); GALNS on the Clock
Aug 7, 2012 07:52 AM Lazard Capital Starts BioMarin Pharmaceutical Inc. (BMRN) at Buy
Aug 2, 2012 10:19 AM Canaccord Genuity on BioMarin (BMRN): November Data + M&A Speculation = Top Pick
Aug 2, 2012 07:25 AM Baird Reiterates an 'Outperform' on BioMarin Pharmaceutical (BMRN); Clean Commercial Platform/Robust Pipeline
Jul 13, 2012 11:21 AM Piper Jaffray Boosts Target on BioMarin (BMRN) to $52 After Addition of BMN-701 to Model
Jun 29, 2012 07:17 AM ThinkEquity Starts BioMarin Pharmaceutical Inc. (BMRN) at Buy
Jun 12, 2012 03:49 PM Piper Jaffray Says BioMarin (BMRN) Could Be Taken Out for $52-$70/Share
Apr 27, 2012 11:35 AM Canaccord Genuity Reiterates a 'Buy' on BioMarin Pharmaceutical (BMRN); Watching The Pipeline
Apr 20, 2012 10:05 AM Canaccord Genuity on Biotechnology: Q1 Earnings Preview - What To Expect
Apr 12, 2012 11:07 AM UPDATE - UBS Initiates Coverage on BioMarin (BMRN) with a Buy; Accumulate on Pullback
Apr 12, 2012 08:18 AM UBS Starts BMRN, RDEA, ARIA at Buy, ITMN, ACHN, HGSI, IRWD at Neutral
Mar 26, 2012 08:58 AM Canaccord Genuity Starts BioMarin Pharmaceutical Inc. (BMRN) at Buy
Mar 19, 2012 07:21 AM Brean Murray Carret & Co. Upgrades BioMarin Pharmaceutical Inc. (BMRN) to Buy; Increased Confidence in GALNS Phase 3 Trial
Feb 22, 2012 07:49 AM Citi Starts BioMarin Pharmaceutical Inc. (BMRN) at Buy
Feb 17, 2012 07:11 AM Baird Reiterates an 'Outperform' BioMarin Pharmaceutical (BMRN); Misses, Guides Lower, but Pipeline Events Remain Key
Dec 15, 2011 11:41 AM Biotech M&A Will Be In Focus in 2012 - Goldman
Oct 17, 2011 08:52 AM Jefferies Raises Numbers On BioMarin (BMRN) After Update from ICHG/ASHG
Sep 28, 2011 07:06 AM Deutsche Bank Upgrades BioMarin Pharmaceutical (BMRN) to Buy; Model Ready to Leverage Promising Pipeline
Sep 23, 2011 07:47 AM Baird Maintains an 'Outperform' on BioMarin Pharmaceutical (BMRN); Valuation Still Attractive, Remains a Core Holding
Sep 16, 2011 07:59 AM RBC Capital Starts BioMarin Pharmaceutical (BMRN) at Outperform
Aug 10, 2011 07:43 AM Piper Jaffray Upgrades BioMarin Pharmaceutical (BMRN) to Overweight
Jul 29, 2011 11:50 AM Jefferies Lilfts Price Target on BioMarin (BMRN)
Apr 29, 2011 11:42 AM Collins Stewart Raises Price Target on BioMarin Pharmaceutical (BMRN) Following Solid Q1 Results and Q2 Guidance
Feb 18, 2011 10:00 AM Jefferies Cuts Estimate & Raises Price Target on BioMarin Pharmaceutical (BMRN), Maintains Buy Rating
Pages: 1 2 3 »» Last Page

Back to BMRN Stock Lookup